A prospective cohort and extended comprehensive-cohort design provided insights about the generalizability of a pragmatic trial: the ProtecT prostate cancer trial

Gelijkaardige items

• Factors associated with trial recruitment, preferences, and treatments received were elucidated in a comprehensive cohort study.
  door: Donovan, JL, et al.
  Gepubliceerd in: (2019)
• Prostate Testing for Cancer and Treatment (ProtecT) feasibility study
  door: J. Donovan, et al.
  Gepubliceerd in: (2003-01-01)
• The ProtecT trial: Analysis of the patient cohort, baseline risk stratification and disease progression
  door: Young, GJ, et al.
  Gepubliceerd in: (2020)
• Modelling the lifetime cost-effectiveness of radical prostatectomy, radiotherapy and active monitoring for men with clinically localised prostate cancer from median 10-year outcomes in the ProtecT randomised trial
  door: S. Sanghera, et al.
  Gepubliceerd in: (2020-10-01)
• Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life.
  door: Lane, A, et al.
  Gepubliceerd in: (2016)